Reducing Cognitive Impairment by Management of Heart Failure as a Modifiable Risk Factor

NARecruitingINTERVENTIONAL
Enrollment

168

Participants

Timeline

Start Date

July 1, 2024

Primary Completion Date

October 31, 2025

Study Completion Date

July 31, 2026

Conditions
Heart FailureCognitive ImpairmentDementiaLeft Ventricular DysfunctionCognitive ChangeCognitive Decline
Interventions
OTHER

Disease management program

"The components of our DMP include:~1. Intensive post-discharge education~2. Home surveillance of signs and symptoms will be reviewed (weekly in the first month and monthly thereafter) in a telehealth consultation with patient and/or carer.~3. Medical treatment involves a planned up-titration of cardioprotective medications that will proceed in the absence of advice from the general practitioner (GP) to the contrary. Close observation and frequent appointments are organised by the nurse with the patient's GP during up-titration period.~4. Exercise program delivered by an exercise physiologist~5. Maintenance phase of the DMP: During this maintenance phase, Intervention patients should have been fully transitioned to home care where they are managed by their GP at optimal doses of their medications. Repeated education and exercise guidance will continue with the carer, supported by our cardiac nurse and exercise physiologist via telehealth consultation bimonthly."

Trial Locations (1)

7000

RECRUITING

Menzies Institute for Medical Research, Hobart

All Listed Sponsors
lead

Baker Heart and Diabetes Institute

OTHER